A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain

Clinical trial NCT01266967 · COMPLETED

Trial details

NCT number: NCT01266967
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma and Brain Metastases

Start date: 2011-02-01
Primary completion: 2011-11-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.